Can a new graft keep dialysis access working longer?

NCT ID NCT05846581

First seen Aug 13, 2026 · Last updated Aug 14, 2026 · Updated 1 time

Summary

This study follows people with end-stage kidney disease who need a vascular graft for hemodialysis. The GORE ACUSEAL graft is placed to create a reliable access point for dialysis. Researchers will track how often the graft becomes infected and how long it stays functional, aiming to see if it holds up well over 24 months. The goal is to gather real-world evidence on the graft's safety and performance in routine clinical care.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
GORE® ACUSEAL Vascular Graft (a medical device used to create vascular access for hemodialysis)
What this could lead to
If successful, this could confirm that the GORE ACUSEAL graft is a safe and reliable option for long-term dialysis access, potentially improving outcomes for people with kidney failure.
What could go wrong
This is an observational study, not a randomized trial, so results may be influenced by patient differences. The graft may still carry risks like infection or blockage, and the study's findings depend on real-world follow-up.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC KIDNEY DISEASES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • ASST-Settelaghi Ospedale di Circolo e Fondazione Macchi

    RECRUITING

    Varese, 21100, Italy

  • Ev. DiakonissenKrankenhaus Leipzigemeinnützige

    RECRUITING

    Leipzig, 04177, Germany

  • Evangelisches Klinikum Bethel (EvKB)

    RECRUITING

    Bielefeld, 33611, Germany

  • North Bristol NHS Trust Southmead Hospital

    TERMINATED

    Bristol, England, BS10 5NB, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.